State Street Corp Nektar Therapeutics Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in Nektar Therapeutics stock. As of the latest transaction made, State Street Corp holds 691,826 shares of NKTR stock, worth $857,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares

691,826

Previous 716,126 3.39%

Holding current value

$857,864

Previous $401,000 60.35%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.49 - $0.96 $11,907 - $23,328	-24,300 Reduced 3.39%	691,826 $643,000
Q3 2023 Nov 14, 2023	SELL	$0.51 - $1.05 $5,003 - $10,301	-9,811 Reduced 1.35%	716,126 $429,000
Q2 2023 Aug 14, 2023	SELL	$0.53 - $1.03 $3.32 Million - $6.44 Million	-6,255,152 Reduced 89.6%	725,937 $421,000
Q1 2023 May 15, 2023	SELL	$0.64 - $3.15 $226,878 - $1.12 Million	-354,498 Reduced 4.83%	6,981,089 $4.89 Million
Q4 2022 Feb 14, 2023	SELL	$2.03 - $4.28 $1.06 Million - $2.23 Million	-521,305 Reduced 6.64%	7,335,587 $16.6 Million

Q3 2022 Nov 15, 2022	SELL	$3.04 - $5.14 $2.65 Million - $4.48 Million	-872,076 Reduced 9.99%	7,856,892 $25.1 Million
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $9.28 Million - $18.1 Million	2,928,666 Added 50.49%	8,728,968 $33.2 Million
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $2.12 Million - $6.98 Million	508,754 Added 9.61%	5,800,302 $31.3 Million
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $6.96 Million - $11.8 Million	642,435 Added 13.82%	5,291,548 $71.5 Million
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $1.29 Million - $1.86 Million	-98,468 Reduced 2.07%	4,649,113 $83.5 Million
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $6.1 Million - $7.53 Million	368,986 Added 8.43%	4,747,581 $81.5 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $1.61 Million - $2.47 Million	-96,981 Reduced 2.17%	4,378,595 $87.6 Million
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $3.56 Million - $4.29 Million	225,455 Added 5.3%	4,475,576 $76.1 Million
Q3 2020 Nov 10, 2020	SELL	$16.59 - $24.79 $3.56 Million - $5.32 Million	-214,526 Reduced 4.8%	4,250,121 $70.5 Million
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $2.81 Million - $3.91 Million	-166,908 Reduced 3.6%	4,464,647 $103 Million
Q1 2020 May 11, 2020	BUY	$14.47 - $27.96 $67 Million - $129 Million	4,631,555 New	4,631,555 $82.7 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $232M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Nektar Therapeutics Transaction History